| Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota K Atarashi, T Tanoue, K Oshima, W Suda, Y Nagano, H Nishikawa, ... Nature 500 (7461), 232-236, 2013 | 2971 | 2013 |
| Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer E Sato, SH Olson, J Ahn, B Bundy, H Nishikawa, F Qian, AA Jungbluth, ... Proceedings of the National Academy of Sciences 102 (51), 18538-18543, 2005 | 2810 | 2005 |
| Regulatory T cells in tumor immunity H Nishikawa, S Sakaguchi International journal of cancer 127 (4), 759-767, 2010 | 1202 | 2010 |
| Regulatory T cells in cancer immunosuppression—implications for anticancer therapy Y Togashi, K Shitara, H Nishikawa Nature reviews Clinical oncology 16 (6), 356-371, 2019 | 1096 | 2019 |
| Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? Y Ohue, H Nishikawa Cancer science 110 (7), 2080-2089, 2019 | 819 | 2019 |
| PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer T Kamada, Y Togashi, C Tay, D Ha, A Sasaki, Y Nakamura, E Sato, ... Proceedings of the National Academy of Sciences 116 (20), 9999-10008, 2019 | 780 | 2019 |
| Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers T Saito, H Nishikawa, H Wada, Y Nagano, D Sugiyama, K Atarashi, ... Nature medicine 22 (6), 679-684, 2016 | 756 | 2016 |
| Regulatory T cells in cancer immunotherapy H Nishikawa, S Sakaguchi Current opinion in immunology 27, 1-7, 2014 | 749 | 2014 |
| Anti-CCR4 mAb selectively depletes effector-type FoxP3+ CD4+ regulatory T cells, evoking antitumor immune responses in humans D Sugiyama, H Nishikawa, Y Maeda, M Nishioka, A Tanemura, ... Proceedings of the National Academy of Sciences 110 (44), 17945-17950, 2013 | 658 | 2013 |
| Regorafenib plus nivolumab in patients with advanced gastric or colorectal cancer: an open-label, dose-escalation, and dose-expansion phase Ib trial (REGONIVO, EPOC1603) S Fukuoka, H Hara, N Takahashi, T Kojima, A Kawazoe, M Asayama, ... Journal of Clinical Oncology 38 (18), 2053-2061, 2020 | 573 | 2020 |
| Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation M Matsumoto, A Baba, T Yokota, H Nishikawa, Y Ohkawa, H Kayama, ... Immunity 41 (6), 1040-1051, 2014 | 571 | 2014 |
| The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies S Kumagai, Y Togashi, T Kamada, E Sugiyama, H Nishinakamura, ... Nature immunology 21 (11), 1346-1358, 2020 | 532 | 2020 |
| Roles of regulatory T cells in cancer immunity Y Takeuchi, H Nishikawa International immunology 28 (8), 401-409, 2016 | 519 | 2016 |
| NY‐ESO‐1: review of an immunogenic tumor antigen S Gnjatic, H Nishikawa, AA Jungbluth, AO Güre, G Ritter, E Jäger, A Knuth, ... Advances in cancer research 95, 1-30, 2006 | 429 | 2006 |
| Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut K Kakihana, Y Fujioka, W Suda, Y Najima, G Kuwata, S Sasajima, ... Blood, The Journal of the American Society of Hematology 128 (16), 2083-2088, 2016 | 371 | 2016 |
| Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments S Kumagai, S Koyama, K Itahashi, T Tanegashima, Y Lin, Y Togashi, ... Cancer Cell 40 (2), 201-218. e9, 2022 | 326 | 2022 |
| Natural and induced T regulatory cells in cancer DO Adeegbe, H Nishikawa Frontiers in immunology 4, 54464, 2013 | 301 | 2013 |
| Tumor‐infiltrating IL‐17‐producing γδ T cells support the progression of tumor by promoting angiogenesis D Wakita, K Sumida, Y Iwakura, H Nishikawa, T Ohkuri, K Chamoto, ... European journal of immunology 40 (7), 1927-1937, 2010 | 287 | 2010 |
| CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses H Nishikawa, T Kato, K Tanida, A Hiasa, I Tawara, H Ikeda, Y Ikarashi, ... Proceedings of the National Academy of Sciences 100 (19), 10902-10906, 2003 | 226 | 2003 |
| CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients H Nishikawa, E Jäger, G Ritter, LJ Old, S Gnjatic Blood 106 (3), 1008-1011, 2005 | 218 | 2005 |
